Antimicrobial Agents and Chemotherapy · 2010 · 47 citations · 11 references
MedicineInfectious DiseasesPharmacologyAntimicrobial PharmacotherapyMedical MicrobiologyMycologyAntifungal AgentsAntifungal PharmacologyAntifungal PharmacotherapyAntifungal TherapyFungal DiagnosticsFungal InfectionsAntifungal ChemotherapyAntifungal Drug MonitoringAntifungal Therapeutic Drug MonitoringLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisPharmacokinetics Of Antifungal DrugsTandem Mass Spectrometry
Therapeutic drug monitoring (TDM) of antifungal plasma concentrations is increasingly recommended. However, data on antifungal concentrations in the other compartments of the peripheral blood are limited. Hence, we collected 23 blood samples from 14 patients receiving posaconazole for prophylaxis of fungal infections. These samples were separated by double-discontinuous Ficoll-Hypaque density gradient centrifugation. The intracellular posaconazole concentrations of the obtained cells, i.e., the peripheral blood mononuclear cells (PBMCs), polymorphonuclear leukocytes (PMNs), and red blood cells (RBCs), were determined by liquid chromatography-tandem mass spectrometry. The intracellular concentrations of the PBMCs and PMNs were significantly higher than those of surrounding media (P < 0.001). The ratios between the intracellular and extracellular concentrations (C/E) were 22.5 +/- 21.2, 7.66 +/- 6.50, and 0.09 +/- 0.05 for the PBMCs, PMNs, and RBCs, respectively. Posaconazole reaches high concentrations within human PBMCs and PMNs and is, to a lesser extent, present in RBCs. The high intracellular concentrations might contribute to posaconazole efficacy and distribution.
11
Andrew J. Ullmann, Oliver A. Cornely, Alexander Burchardt et al. · Antimicrobial Agents and Chemotherapy · 2006 · 272 citations · Full text
Fedja Farowski, Oliver A. Cornely, Jörg Janne Vehreschild et al. · Antimicrobial Agents and Chemotherapy · 2010 · 84 citations · Full text